Laflavon™
Laflavon™ is a proprietary blend of soy isoflavones designed to target abnormalities of glucose turnover and improve insulin sensitivity.
Studies with Laflavon™ have shown it can radically enhance the functioning and efficacy of the hormone insulin, which is the key agent regulating blood fat and sugar levels. Once the body becomes resistant to insulin as a result of excessive food consumption, diabetes with its associated damage to the major organs from abnormal fat and sugar levels in blood, is inevitable. In addition, loss of proper response to insulin leads to increased levels of lipid in the circulation, which increases deposits of lipids in blood vessels.
Insulin resistance, glucose tolerance and hyperlipidemia are key features of “metabolic syndrome”, which has become increasingly common in the developed world. It is estimated that in America
alone it affects over 100 million people.
Laflavon™ is expected to be of benefit to anyone with metabolic syndrome or pre-diabetes, as well as being of interest to any consumer at risk of developing these syndromes or generally wishing to maximise their health.
Laflavon™ is made to GMP standards for CamMEDICA by Indena, Milan.